The firm's overall revenue rose 8 percent, driven by growth in established pharmaceuticals and medical devices.

Pathologists at academic medical centers are using intentional change-management strategies to overcome some intangible barriers digital uptake.

The deal will help CHOP to expand the reach of its diagnostic innovations, allow Labcorp to grow its offerings, and enable the parties to combine resources to accelerate test development.

With the mark, the system, a fully automated blood culture platform meant for diagnosing bloodstream infections, can be sold throughout the EU.

The test, which leverages technology that mimics a dog's ability to sense disease in humans, analyzes cancer-associated volatile organic compounds found in urine samples.

NEW YORK – Roche on Monday announced that it has received CE marking for a blood test to detect neuroinflammation in patients with multiple sclerosis. The Elecsys Neurofilament Light Chain test ...

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

The parties will work on tests in areas including cancer, genetics, immune disorders, and rare diseases and streamline the path from discovery to national availability.

The assay measures three host-immune proteins to indicate the likelihood of bacterial or viral infections, and is validated for use on Beckman Coulter immunoassay analyzers.